Single arm, phase II study, MR (Magnetic Resonance Imaging) - based IGRT (Image-guided radiotherapy) of prostate cancer.
Primary endpoint: Grade 2+ GI (gastrointestinal) and genitourinary (GU) toxicity after 2 years.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
histologically proven prostate cancer
indication for curative treatment
ECOG performance scale 0-2
Informed consent
You may not be if
contraindications for curative treatment
age\<18year
previous pelvic radiotherapy or prostatic treatment like TURP (transurethral resection of prostate), HIFU (high intensity focused ultrasound)
serious comorbidity leading to inability for IGRT (image-guided radiotherapy)
contraindications for MRI (Magnetic Resonance Imaging)
Clareo Health | Study of MR-based IGRT for Prostate Cancer
